Neumora Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.11 M | $75.33 M | 14.87% | 4.46% |
SOFTBANK GROUP CORP. | 02/14/2025 | 6.54 M | $69.34 M | -13.33% | 4.10% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 5.00 M | $53.03 M | -4.31% | 3.14% |
MIC CAPITAL MANAGEMENT UK LLP | 02/14/2025 | 4.46 M | $47.28 M | 0.00% | 2.80% |
SIREN, L.L.C. | 02/14/2025 | 4.40 M | $46.60 M | 68.65% | 2.76% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 4.00 M | $42.40 M | 604.94% | 2.51% |
CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 3.70 M | $39.22 M | 692.06% | 2.32% |
WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST | 01/13/2025 | 3.31 M | $35.08 M | 0.00% | 2.08% |
ICONIQ CAPITAL, LLC | 02/14/2025 | 2.56 M | $27.13 M | -24.70% | 1.61% |
LUNATE HOLDING RSC LTD | 02/14/2025 | 2.12 M | $22.52 M | 100.00% | 1.33% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 2.07 M | $21.96 M | 0.00% | 1.30% |
JOHNSON & JOHNSON | 02/13/2025 | 1.85 M | $19.60 M | 0.00% | 1.16% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 1.52 M | $16.10 M | 653.17% | 0.95% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.50 M | $15.90 M | 100.00% | 0.94% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 1.19 M | $12.61 M | 559.17% | 0.75% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 1.03 M | $10.97 M | 0.00% | 0.65% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 955,106 | $10.12 M | 15.34% | 0.60% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 900,000 | $9.54 M | 125.00% | 0.56% |
ORBIMED ADVISORS LLC | 02/14/2025 | 804,996 | $8.53 M | -46.33% | 0.51% |
SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 636,300 | $6.74 M | 100.00% | 0.40% |
CALLAN CAPITAL, LLC | 02/03/2025 | 636,194 | $6.74 M | -3.78% | 0.40% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 633,300 | $6.71 M | 100.00% | 0.40% |
LMR PARTNERS LLP | 02/14/2025 | 616,400 | $6.53 M | 507.29% | 0.39% |
CANDRIAM S.C.A. | 02/07/2025 | 571,027 | $6.05 M | -15.56% | 0.36% |
SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 521,013 | $5.52 M | 273.92% | 0.33% |
AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 475,000 | $5.04 M | 100.00% | 0.30% |
STEMPOINT CAPITAL LP | 02/14/2025 | 428,137 | $4.54 M | 100.00% | 0.27% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 350,000 | $3.71 M | -12.50% | 0.22% |
WOODLINE PARTNERS LP | 02/14/2025 | 310,454 | $3.29 M | 0.94% | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 289,300 | $3.07 M | 147.27% | 0.18% |
SOROS CAPITAL MANAGEMENT LLC | 02/14/2025 | 279,333 | $2.96 M | -45.11% | 0.18% |
WEXFORD CAPITAL LP | 02/14/2025 | 252,122 | $2.67 M | 15.72% | 0.16% |
CERITY PARTNERS LLC | 02/13/2025 | 243,908 | $2.59 M | 0.42% | 0.15% |
ADDIS & HILL, INC | 01/31/2025 | 163,386 | $1.73 M | -45.54% | 0.10% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 150,936 | $1.60 M | -2.00% | 0.09% |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 150,000 | $1.59 M | 0.00% | 0.09% |
AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 150,000 | $1.59 M | 100.00% | 0.09% |
CUTTER CAPITAL MANAGEMENT, LP | 02/14/2025 | 150,000 | $1.59 M | 100.00% | 0.09% |
ALPS ADVISORS INC | 02/13/2025 | 130,644 | $1.38 M | 10.56% | 0.08% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 104,776 | $1.11 M | 100.00% | 0.07% |
WINDMILL HILL ASSET MANAGEMENT LTD | 02/26/2025 | 104,373 | $1.11 M | 299.58% | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 101,000 | $1.07 M | -13.68% | 0.06% |
02/14/2025 | 81,200 | $860,720 | 100.00% | 0.05% | |
BREVAN HOWARD CAPITAL MANAGEMENT LP | 02/14/2025 | 80,559 | $853,925 | 100.00% | 0.05% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 68,608 | $727,245 | 100.00% | 0.04% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 68,418 | $725,231 | -54.51% | 0.04% |
GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 66,669 | $706,691 | 100.00% | 0.04% |
HAP TRADING, LLC | 02/13/2025 | 53,800 | $17,155 | 100.00% | 0.03% |
NUMERAI GP LLC | 02/14/2025 | 51,696 | $547,978 | 46.70% | 0.03% |
LMR PARTNERS LLP | 02/14/2025 | 50,000 | $530,000 | 100.00% | 0.03% |
Neumora Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 85 institutional investors and hedge funds held shares of Neumora Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 7.11 M
SOFTBANK GROUP CORP.: 6.54 M
T. Rowe Price Investment Management, Inc.: 5 M
MIC Capital Management UK LLP: 4.46 M
Siren, L.L.C.: 4.4 M
Deep Track Capital, LP: 4 M
50.43% of Neumora Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 55.61 M shares in the last 24 months. This purchase volume represents approximately $137.92 M in transactions.